Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4166000
Max Phase: Preclinical
Molecular Formula: C59H98N12O12
Molecular Weight: 1167.50
Molecule Type: Small molecule
Associated Items:
ID: ALA4166000
Max Phase: Preclinical
Molecular Formula: C59H98N12O12
Molecular Weight: 1167.50
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: CC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@H]1CCCCCCC[C@@H](C(=O)N(C)C)NC(=O)[C@@H]2CCCN2C(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC1=O
Standard InChI: InChI=1S/C59H98N12O12/c1-34(2)30-45(63-39(9)72)53(77)61-37(7)50(74)67-47(32-36(5)6)55(79)64-43(21-17-18-28-60)52(76)69-48(33-40-24-26-41(73)27-25-40)56(80)65-42-20-15-13-12-14-16-22-44(59(83)70(10)11)66-57(81)49-23-19-29-71(49)58(82)38(8)62-54(78)46(31-35(3)4)68-51(42)75/h24-27,34-38,42-49,73H,12-23,28-33,60H2,1-11H3,(H,61,77)(H,62,78)(H,63,72)(H,64,79)(H,65,80)(H,66,81)(H,67,74)(H,68,75)(H,69,76)/t37-,38-,42-,43-,44-,45-,46-,47-,48-,49-/m0/s1
Standard InChI Key: QCSCXIPKCCVXFV-MOLHNXBOSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 1167.50 | Molecular Weight (Monoisotopic): 1166.7427 | AlogP: | #Rotatable Bonds: |
Polar Surface Area: | Molecular Species: | HBA: | HBD: |
#RO5 Violations: | HBA (Lipinski): | HBD (Lipinski): | #RO5 Violations (Lipinski): |
CX Acidic pKa: | CX Basic pKa: | CX LogP: | CX LogD: |
Aromatic Rings: | Heavy Atoms: | QED Weighted: | Np Likeness Score: |
1. Chen X, Liu L, Chen Y, Yang Y, Yang CY, Guo T, Lei M, Sun H, Wang S.. (2018) Cyclic Peptidic Mimetics of Apollo Peptides Targeting Telomeric Repeat Binding Factor 2 (TRF2) and Apollo Interaction., 9 (5): [PMID:29795768] [10.1021/acsmedchemlett.8b00152] |
2. Chen X,Dong Y,Guo T,Yang CY,Chen Y,Sun H. (2020) N-terminal modified cyclopeptidic mimetics of Apollo as inhibitors of TRF2., 30 (21.0): [PMID:32871539] [10.1016/j.bmcl.2020.127401] |
Source(1):